Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 12/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/23

Curator: Scholastica

Revision editor(s): Scholastica

Source: Supplementary Fig. S6B

Description: Differentially significant abundant taxa in breast cancer patients before Chemotherapy with increased BMI compared to those without increased BMI

Abundance in Group 1: increased abundance in Yes - increased BMI (Pre-Chemo)

NCBI	Quality Control	Links
Bacteroides stercoris
Parabacteroides merdae
Anaeromassilibacillus sp. An250
Bacteroides finegoldii
Bacteroides cellulosilyticus
Ruthenibacterium lactatiformans
Bifidobacterium catenulatum
Coprobacillus cateniformis
Coprobacter secundus
Prevotella disiens
Phocaeicola vulgatus
Firmicutes bacterium CAG:94
Segatella copri
Butyricimonas virosa
Blautia obeum
Bifidobacterium animalis
Ruminococcus sp. CAG:403
Adlercreutzia equolifaciens
Bacteroides eggerthii
Clostridium paraputrificum
Eubacterium sp. CAG:180
Firmicutes bacterium CAG:95
Dialister succinatiphilus
Anaerotruncus sp. CAG:528
Parabacteroides distasonis
Clostridiales bacterium 1_7_47FAA
Candidatus Gastranaerophilales bacterium
Oscillibacter sp. 57_20
Adlercreutzia equolifaciens subsp. celatus
Clostridium disporicum
Thomasclavelia ramosa
Oscillibacter sp. CAG:241
Mitsuokella jalaludinii
Dielma fastidiosa
Veillonella atypica
Flavonifractor sp. An100
Turicimonas muris
Odoribacter splanchnicus
Bifidobacterium bifidum
Prevotella sp. CAG:1185

Revision editor(s): Scholastica